Chapter 1 Insomnia Therapeutics Market Overview
1.1 Insomnia Therapeutics Definition
1.2 Global Insomnia Therapeutics Market Size Status and Outlook (2018-2032)
1.3 Global Insomnia Therapeutics Market Size Comparison by Region (2018-2032)
1.4 Global Insomnia Therapeutics Market Size Comparison by Type (2018-2032)
1.5 Global Insomnia Therapeutics Market Size Comparison by Application (2018-2032)
1.6 Global Insomnia Therapeutics Market Size Comparison by Sales Channel (2018-2032)
1.7 Insomnia Therapeutics Market Dynamics
1.7.1 Market Drivers/Opportunities
1.7.2 Market Challenges/Risks
1.7.3 Market News (Merger/Acquisition/Expansion)
1.7.4 Key Trends in Insomnia Therapeutics Market
Chapter 2 Insomnia Therapeutics Market Competition by Player
2.1 Global Insomnia Therapeutics Sales and Market Share by Player (2021-2023)
2.2 Global Insomnia Therapeutics Revenue and Market Share by Player (2021-2023)
2.3 Global Insomnia Therapeutics Average Price by Player (2021-2023)
2.4 Players Competition Situation & Trends
2.5 Conclusion of Segment by Player
Chapter 3 Insomnia Therapeutics Market Segment by Type
3.1 Global Insomnia Therapeutics Market by Type
3.1.1 Benzodiazepines
3.1.2 Nonbenzodiazepines
3.1.3 Antidepressants
3.1.4 Orexin Antagonists
3.1.5 Melatonin Antagonists
3.2 Global Insomnia Therapeutics Sales and Market Share by Type (2018-2023)
3.3 Global Insomnia Therapeutics Revenue and Market Share by Type (2018-2023)
3.4 Global Insomnia Therapeutics Average Price by Type (2018-2023)
3.5 Conclusion of Segment by Type
Chapter 4 Insomnia Therapeutics Market Segment by Application
4.1 Global Insomnia Therapeutics Market by Application
4.1.1 Hospital Pharmacies
4.1.2 Retail Pharmacies
4.1.3 Online Pharmacies
4.2 Global Insomnia Therapeutics Revenue and Market Share by Application (2018-2023)
4.3 Conclusion of Segment by Application
Chapter 5 Insomnia Therapeutics Market Segment by Sales Channel
5.1 Global Insomnia Therapeutics Market by Sales Channel
5.1.1 Direct Channel
5.1.2 Distribution Channel
5.2 Global Insomnia Therapeutics Revenue and Market Share by Sales Channel (2018-2023)
5.3 Conclusion of Segment by Sales Channel
Chapter 6 Insomnia Therapeutics Market Segment by Region & Country
6.1 Global Insomnia Therapeutics Market Size and CAGR by Region (2018-2032)
6.2 Global Insomnia Therapeutics Sales and Market Share by Region (2018-2023)
6.3 Global Insomnia Therapeutics Revenue and Market Share by Region (2018-2023)
6.4 North America
6.4.1 North America Market by Country
6.4.2 North America Insomnia Therapeutics Market Share by Type
6.4.3 North America Insomnia Therapeutics Market Share by Application
6.4.4 United States
6.4.5 Canada
6.5 Europe
6.5.1 Europe Market by Country
6.5.2 Europe Insomnia Therapeutics Market Share by Type
6.5.3 Europe Insomnia Therapeutics Market Share by Application
6.5.4 Germany
6.5.5 UK
6.5.6 France
6.5.7 Italy
6.5.8 Spain
6.5.9 Russia
6.6 Asia-Pacific
6.6.1 Asia-Pacific Market by Country
6.6.2 Asia-Pacific Insomnia Therapeutics Market Share by Type
6.6.3 Asia-Pacific Insomnia Therapeutics Market Share by Application
6.6.4 China
6.6.5 Japan
6.6.6 Korea
6.6.7 India
6.6.8 Southeast Asia
6.6.9 Australia
6.7 South America
6.7.1 South America Market by Country
6.7.2 South America Insomnia Therapeutics Market Share by Type
6.7.3 South America Insomnia Therapeutics Market Share by Application
6.7.4 Brazil
6.7.5 Mexico
6.7.6 Argentina
6.7.7 Colombia
6.8 Middle East & Africa
6.8.1 Middle East & Africa Market by Country
6.8.2 Middle East & Africa Insomnia Therapeutics Market Share by Type
6.8.3 Middle East & Africa Insomnia Therapeutics Market Share by Application
6.8.4 Turkey
6.8.5 UAE
6.8.6 Saudi Arabia
6.8.7 South Africa
6.9 Conclusion of Segment by Region
Chapter 7 Profile of Leading Insomnia Therapeutics Players
7.1 Merck
7.1.1 Company Snapshot
7.1.2 Product/Service Offered
7.1.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)
7.2 Eisai
7.3 Meda Consumer Healthcare
7.4 Takeda Pharmaceuticals
7.5 Pfizer
7.6 Sanofi
7.7 Vanda Pharmaceuticals
7.8 Pernix Therapeutics
7.9 Purdue Pharmaceuticals
7.10 Mylan
7.11 Teva Pharmaceutical
7.12 Sumitomo Dainippon Pharma
7.13 Paratek Pharmaceuticals
7.14 Ebb Therapeutics
7.15 Astellas
7.16 Dainippon Sumitomo
7.17 Flynn Pharma
7.18 Johnson & Johnson
7.19 Somnus Therapeutics
7.20 Neurim
7.21 Minerva Neurosciences
7.22 SkyePharma
Chapter 8 Upstream and Downstream Analysis of Insomnia Therapeutics
8.1 Industrial Chain of Insomnia Therapeutics
8.2 Upstream of Insomnia Therapeutics
8.3 Downstream of Insomnia Therapeutics
Chapter 9 Development Trend of Insomnia Therapeutics (2024-2032)
9.1 Global Insomnia Therapeutics Market Size (Sales and Revenue) Forecast (2024-2032)
9.2 Global Insomnia Therapeutics Market Size and CAGR Forecast by Region (2024-2032)
9.3 Global Insomnia Therapeutics Market Size and CAGR Forecast by Type (2024-2032)
9.4 Global Insomnia Therapeutics Market Size and CAGR Forecast by Application (2024-2032)
9.5 Global Insomnia Therapeutics Market Size and CAGR Forecast by Sales Channel (2024-2032)
Chapter 10 Appendix
10.1 Research Methodology
10.2 Data Sources
10.3 Disclaimer
10.4 Analysts Certification
